Significant reduction of sertraline plasma levels by carbamazepine and phenytoin (Q43949974)

28 November 2017

Significant reduction of sertraline plasma levels by carbamazepine and phenytoin (English)

1 reference

28 November 2017

1 reference

1 reference

2

1 reference

28 November 2017

Maria Pihlsgård

1

1 reference

28 November 2017

1 February 2002

1 reference

European Journal of Clinical Pharmacology

28 November 2017

1 reference

28 November 2017

57

1 reference

28 November 2017

12

1 reference

28 November 2017

915-916

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-001-0416-3

28 November 2017

0 references

cites work

The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders

2 references

https://api.crossref.org/works/10.1007%2FS00228-001-0416-3

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/11936714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A mechanistic approach to antiepileptic drug interactions

1 reference

https://api.crossref.org/works/10.1007%2FS00228-001-0416-3

Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-001-0416-3

Lack of sertraline efficacy probably due to an interaction with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-001-0416-3

Sertraline N-demethylation is catalyzed by multiple isoforms of human cytochrome P-450 in vitro.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11936714

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00228-001-0416-3

1 reference

28 November 2017

1 reference

PubMed ID

11936714